Study Links Type 2 Diabetes Treatment to Increased Colorectal Cancer Risk

A recent study published in BMC Gastroenterology reveals a significant link between Type 2 diabetes (T2D) and colorectal cancer (CRC), particularly concerning the use of sulfonylureas. The research indicates that while T2D may initially seem to increase CRC risk, sulfonylurea usage shows a consistent association with higher CRC likelihood. These findings underscore the need for healthcare providers to reassess diabetes treatment plans and emphasize regular CRC screenings for patients with T2D.